Medical News

RSS

3M announces availability of TLR compounds for nonvaccine use in pharmaceutical industry

3M announces the availability of immune response modifier compounds for nonvaccine use in the pharmaceutical industry. The toll-like receptor (TLR) compounds, that activate through TLR7 and TLR8, show promise for the treatment of conditions including cancer, dermatologic diseases and atopic diseases, such as allergy and asthma.

3 Dec 2010

CRT therapy is cost-effective for symptomatic heart failure patients: REVERSE trial

Medtronic, Inc. announced findings from an economic sub-study of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial published in the European Heart Journal demonstrating for the first time that cardiac resynchronization therapy (CRT) is cost-effective in mildly symptomatic heart failure (HF) patients.

3 Dec 2010

Cardiac surgeons are trying innovative approaches to traditional open heart surgery

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, cardiac surgeons are trying new innovative approaches to traditional open heart surgery as they try to make coronary artery bypass graft (CABG) procedures less invasive where possible.

3 Dec 2010

New national awards program to recognize healthcare institutions to eliminate HAI infection

A new national awards program will recognize teams of critical care professionals and healthcare institutions able to successfully reduce or eliminate healthcare-associated infections (HAI), a leading cause of death in the United States.

3 Dec 2010

Scripps scientists find way to transform mature human cells into stem cells

Scripps Research Institute scientists have made a significant leap forward in the drive to find a way to safely reprogram mature human cells and turn them into stem cells, which can then change into other cell types, such as nerve, heart, and liver cells. The ability to transform fully mature adult cells such as skin cells into stem cells has potentially profound implications for treating many diseases.

3 Dec 2010

Biomagnetics updates prototype bench top version of IOBS biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced that an updated prototype bench top version of the Integrated Optical Biosensor, originally developed at Los Alamos for research purposes, is now complete.

3 Dec 2010

Number of medical school graduates increasing; average age of physicians stabilizing

Canada experienced the biggest annual percentage gain in the national supply of physicians since the late 1980s, according to a new report released today by the Canadian Institute for Health Information (CIHI). In 2009, there were approximately 68,100 active physicians working in Canada, an increase of nearly 2,700 physicians over the previous year. This represents an increase of 4.1%—more than triple the rate of growth of the Canadian population as a whole (1.2%) and the largest annual increase of the past two decades.

3 Dec 2010

New robotic arm device for early to mid-stage osteoarthritis

A robotic arm device developed to assist orthopedic surgeons with performing partial knee replacement surgery for early to mid-stage osteoarthritis is now available at NewYork-Presbyterian Hospital/Columbia University Medical Center. The technology was approved by the FDA in 2005, and to date nearly 5,000 cases have been performed in the U.S.

3 Dec 2010

Access MediQuip enters agreement with BCBSTX to provide implant surgical management

Access MediQuip, LLC, the largest provider of surgical implant management solutions in the country and Blue Cross and Blue Shield of Texas (BCBSTX), the largest provider of health benefits in Texas, announced today an agreement for Access MediQuip to provide specialized implant surgical management services to BCBSTX's vast membership across the State of Texas. Implementation will begin in December 2010.

3 Dec 2010

Cell Therapeutics submits pixantrone NDA application to treat non-Hodgkin's lymphoma

Cell Therapeutics, Inc. today announced that it has submitted a formal appeal to the Office of New Drugs in the U.S. Food and Drug Administration's Center for Drug Evaluation and Research regarding the agency's decision from earlier this year on the pixantrone New Drug Application to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.

3 Dec 2010

UCLA findings could lead to enhanced health supplements, progress on Parkinson's

The discovery by UCLA biochemists of a new method for preventing oxidation in the essential fatty acids of cell membranes could lead to a new class of more effective nutritional supplements and potentially help combat neurodegenerative disorders such as Parkinson's disease and perhaps Alzheimer's.

3 Dec 2010

IP-K signs agreement to continue NITD research deal for new drug candidates

Institut Pasteur Korea (IP-K) has signed an agreements to continue to mine the chemical compound collection of Novartis Institute for Tropical Diseases (NITD) of Singapore for new drug candidates.

3 Dec 2010

Arthritis drug reduces incidence of non-melanoma skin cancers

A widely-used arthritis drug reduces the incidence of non-melanoma skin cancers - the most common cancers in humans - according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas.

3 Dec 2010

NIAID researchers develop new method to detect prion diseases

A fast test to diagnose fatal brain conditions such as mad cow disease in cattle and Creutzfeldt-Jakob disease in humans could be on the horizon, according to a new study from National Institutes of Health scientists. Researchers at NIH's National Institute of Allergy and Infectious Diseases (NIAID) have developed a highly sensitive and rapid new method to detect and measure infectious agents called prions that cause these diseases.

3 Dec 2010

Sagent launches chemotherapy agent topotecan hydrochloride for injection

Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA approval and launch of its topotecan hydrochloride for injection, a chemotherapy agent, in conjunction with the innovator's patent expiry. Sagent's topotecan is available in 4 mg single-dose latex-free vials.

3 Dec 2010

New scientifically-based family planning tool

A scientifically-based family planning tool developed by researchers from Georgetown University's Institute for Reproductive Health, a part of Georgetown University Medical Center (GUMC), is now available as an easy-to-use iPhone -, iPod touch- or iPad- application. iCycleBeads- is the first software application that enables a woman to plan or avoid pregnancy easily and effectively, entirely through the information provided by the application.

3 Dec 2010

Sentara Heart Hospital commences procedures in AtriCure DEEP AF feasibility trial

Sentara Heart Hospital is breaking new ground in cardiac care and treatment. Surgeons and Cardiologists at Sentara Heart Hospital are first to begin enrolling and performing trial cases in the AtriCure DEEP AF feasibility trial. The first procedure in the country was performed in a new, state-of-the-art hybrid operating room at Sentara Heart Hospital by Jonathan Philpott, M.D., Director of the Sentara Atrial Fibrillation Surgery Program, Ian Woollett, M.D., and John Onufer, M.D., Medical Director of Cardiac Electrophysiology.

3 Dec 2010

IP-K signs agreement with sanofi-aventis to identify new medicines

Institut Pasteur Korea (IP-K) has signed an agreement with sanofi-aventis Research & Development of Toulouse, France to continue research on the identification of new medicines.

3 Dec 2010

Democrats confident food safety bill will be resolved despite procedural error; Child nutrition bill set for house vote

The Hill's Healthwatch Blog: "Senate Democrats say an error in the food-safety bill passed Tuesday can be resolved in time to send the legislation to President Obama by the end of the year. Two senior leadership aides confirmed that the bill the Senate approved, 73-25, inadvertently contained tax provisions that, under the Constitution, must originate in the House of Representatives. That means the bill must be passed a second time by the Senate, giving critics such as Sen. Tom Coburn (R-Okla.) another chance to block it" (Rushing and Lillis, 12/1).

3 Dec 2010

Dysfunction in blood vessels plays a role in Alzheimer's disease development

A dysfunction in the lining of blood vessels that is linked to cardiovascular illness also appears to play a role in the development of Alzheimer's disease, according to a study published in Circulation Research: Journal of the American Heart Association.

3 Dec 2010

Medical News

3M announces availability of TLR compounds for nonvaccine use in pharmaceutical industry

CRT therapy is cost-effective for symptomatic heart failure patients: REVERSE trial

Cardiac surgeons are trying innovative approaches to traditional open heart surgery

New national awards program to recognize healthcare institutions to eliminate HAI infection

Scripps scientists find way to transform mature human cells into stem cells

Biomagnetics updates prototype bench top version of IOBS biosensor

Number of medical school graduates increasing; average age of physicians stabilizing

New robotic arm device for early to mid-stage osteoarthritis

Access MediQuip enters agreement with BCBSTX to provide implant surgical management

Cell Therapeutics submits pixantrone NDA application to treat non-Hodgkin's lymphoma

UCLA findings could lead to enhanced health supplements, progress on Parkinson's

IP-K signs agreement to continue NITD research deal for new drug candidates

Arthritis drug reduces incidence of non-melanoma skin cancers

NIAID researchers develop new method to detect prion diseases

Sagent launches chemotherapy agent topotecan hydrochloride for injection

New scientifically-based family planning tool

Sentara Heart Hospital commences procedures in AtriCure DEEP AF feasibility trial

IP-K signs agreement with sanofi-aventis to identify new medicines

Democrats confident food safety bill will be resolved despite procedural error; Child nutrition bill set for house vote

Dysfunction in blood vessels plays a role in Alzheimer's disease development

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News